331 related articles for article (PubMed ID: 33847139)
1. The interplay of SARS-CoV-2 and
Khanna S; Kraft CS
Future Microbiol; 2021 Apr; 16():439-443. PubMed ID: 33847139
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.
Bentivegna E; Alessio G; Spuntarelli V; Luciani M; Santino I; Simmaco M; Martelletti P
Am J Infect Control; 2021 May; 49(5):640-642. PubMed ID: 33031863
[TBL] [Abstract][Full Text] [Related]
3. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19.
Laszkowska M; Kim J; Faye AS; Joelson AM; Ingram M; Truong H; Silver ER; May B; Greendyke WG; Zucker J; Lebwohl B; Hur C; Freedberg DE
Dig Dis Sci; 2021 Dec; 66(12):4398-4405. PubMed ID: 33479861
[TBL] [Abstract][Full Text] [Related]
5. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
6. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
[TBL] [Abstract][Full Text] [Related]
7. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
8. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
9. Severe
Páramo-Zunzunegui J; Ortega-Fernández I; Calvo-Espino P; Diego-Hernández C; Ariza-Ibarra I; Otazu-Canals L; Danés-Grases JE; Menchero-Sánchez A
Ann R Coll Surg Engl; 2020 Sep; 102(7):e176-e179. PubMed ID: 32803988
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
Spigaglia P
Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
[TBL] [Abstract][Full Text] [Related]
12. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.
Maldonado-Barrueco A; Moreno-Ramos F; Díaz-Pollán B; Loeches-Yagüe B; Rico-Nieto A; García-Rodríguez J; Ruiz-Carrascoso G
Anaerobe; 2024 Apr; 86():102836. PubMed ID: 38428802
[TBL] [Abstract][Full Text] [Related]
13.
Maslennikov R; Ivashkin V; Ufimtseva A; Poluektova E; Ulyanin A
Future Microbiol; 2022 Jun; 17():653-663. PubMed ID: 35440149
[TBL] [Abstract][Full Text] [Related]
14. Clostridioides difficile infection in the COVID-19 era: old and new problems.
Spigaglia P
Pol Arch Intern Med; 2021 Feb; 131(2):118-120. PubMed ID: 33641318
[No Abstract] [Full Text] [Related]
15. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
Sandhu A; Tillotson G; Polistico J; Salimnia H; Cranis M; Moshos J; Cullen L; Jabbo L; Diebel L; Chopra T
Emerg Infect Dis; 2020 Sep; 26(9):2272-4. PubMed ID: 32441243
[TBL] [Abstract][Full Text] [Related]
16.
Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
[No Abstract] [Full Text] [Related]
17. COVID-19 and coinfection with Clostridioides (Clostridium) difficile in an infant with gastrointestinal manifestation.
Oba J; Silva CA; Toma RK; Carvalho WB; Delgado AF
Einstein (Sao Paulo); 2020; 18():eRC6048. PubMed ID: 33295435
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
Khanna S; Pardi D
Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
[No Abstract] [Full Text] [Related]
19. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent
Satokari R; Pietilä L; Mattila E; Lahtinen P; Arkkila PET
Infect Dis (Lond); 2020 Sep; 52(9):662-665. PubMed ID: 32516025
[No Abstract] [Full Text] [Related]
20. Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic.
Chiu CH; Tsai MC; Cheng HT; Le PH; Kuo CJ; Chiu CT
J Formos Med Assoc; 2021 Feb; 120(2):791-793. PubMed ID: 32713786
[No Abstract] [Full Text] [Related]
[Next] [New Search]
